Quest Diagnostics Inc (DGX)
128.45
+2.54
(+2.02%)
USD |
NYSE |
Apr 19, 16:00
128.45
0.00 (0.00%)
After-Hours: 20:00
Quest Diagnostics Free Cash Flow: 864.00M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 864.00M |
| September 30, 2023 | 596.00M |
| June 30, 2023 | 878.00M |
| March 31, 2023 | 864.00M |
| December 31, 2022 | 1.314B |
| September 30, 2022 | 1.464B |
| June 30, 2022 | 1.552B |
| March 31, 2022 | 1.602B |
| December 31, 2021 | 1.83B |
| September 30, 2021 | 1.872B |
| June 30, 2021 | 2.171B |
| March 31, 2021 | 2.068B |
| December 31, 2020 | 1.587B |
| September 30, 2020 | 1.384B |
| June 30, 2020 | 816.00M |
| March 31, 2020 | 779.00M |
| December 31, 2019 | 843.00M |
| September 30, 2019 | 811.00M |
| June 30, 2019 | 929.00M |
| March 31, 2019 | 938.00M |
| December 31, 2018 | 817.00M |
| September 30, 2018 | 914.00M |
| June 30, 2018 | 892.00M |
| March 31, 2018 | 876.00M |
| December 31, 2017 | 923.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 905.00M |
| June 30, 2017 | 846.00M |
| March 31, 2017 | 871.00M |
| December 31, 2016 | 823.00M |
| September 30, 2016 | 778.00M |
| June 30, 2016 | 698.00M |
| March 31, 2016 | 668.00M |
| December 31, 2015 | 558.00M |
| September 30, 2015 | 600.00M |
| June 30, 2015 | 609.00M |
| March 31, 2015 | 616.00M |
| December 31, 2014 | 636.00M |
| September 30, 2014 | 550.00M |
| June 30, 2014 | 518.00M |
| March 31, 2014 | 439.00M |
| December 31, 2013 | 421.00M |
| September 30, 2013 | 607.56M |
| June 30, 2013 | 820.27M |
| March 31, 2013 | 871.73M |
| December 31, 2012 | 1.005B |
| September 30, 2012 | 978.59M |
| June 30, 2012 | 927.27M |
| March 31, 2012 | 743.68M |
| December 31, 2011 | 734.00M |
| September 30, 2011 | 710.33M |
Free Cash Flow Range, Past 5 Years
596.00M
Minimum
Sep 2023
2.171B
Maximum
Jun 2021
1.275B
Average
1.314B
Median
Dec 2022
Free Cash Flow Benchmarks
| Laboratory Corp of America Holdings | 874.10M |
| Exact Sciences Corp | 31.93M |
| Delcath Systems Inc | -31.31M |
| CytoSorbents Corp | -22.59M |
| Progyny Inc | 185.17M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 527.00M |
| Cash from Investing (Quarterly) | -114.00M |
| Cash from Financing (Quarterly) | 130.00M |
| Free Cash Flow Per Share (Quarterly) | 4.062 |
| Free Cash Flow to Equity (Quarterly) | -137.00M |
| Free Cash Flow to Firm (Quarterly) | 488.25M |
| Free Cash Flow Yield | 5.94% |